NCT07839325

Brief Summary

Lung cancer patients often go through more than one type of treatment, such as chemotherapy, radiation, and immunotherapy. These treatments can lead to several transition periods, which may increase stress and leave some needs unmet for patients and their family caregivers. The purpose of this study is to find out whether a program that includes mindfulness (stress reduction) and education is helpful, acceptable, and practical for lung cancer patients and their family caregivers. We also want to learn if this program helps them feel better prepared during these transitions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Sep 2026May 2028

First Submitted

Initial submission to the registry

August 24, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 24, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

September 24, 2026

Status Verified

September 1, 2026

Enrollment Period

1.2 years

First QC Date

August 24, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

post-treatment survivorshipmindfulness-based stress reductionlung cancercaregiverstresshealthy lifestyle

Outcome Measures

Primary Outcomes (6)

  • Recruitment Rate Assessed Using Study Recruitment Records

    Number of participants enrolled divided by the number of eligible participants approached for participation

    through study completion, an average of 1.5 year

  • Retention Rate Assessed Using Study Completion Records

    Number of enrolled participants who completed the study through the final assessment divided by the number enrolled

    through study completion, an average of 1.5 year

  • Intervention Adherence Assessed Using Intervention Tracking Records

    Number/proportion of prescribed intervention activities or sessions completed according to the intervention protocol

    through study completion, an average of 1.5 year

  • Session Attendance Assessed Using Intervention Attendance Logs

    Number and percentage of scheduled intervention sessions attended by each

    through study completion, an average of 1.5 year

  • Participant Satisfaction Assessed by the Client Satisfaction Questionnaire Adapted to Internet-Based Interventions (CSQ-I)

    Participant satisfaction with the intervention will be assessed using the Client Satisfaction Questionnaire adapted to Internet-based interventions (CSQ-I). Scores from all 8 items are summed to produce a total score ranging from 8 to 32, with higher scores indicating greater satisfaction with the intervention.

    Week 8

  • Intervention Acceptability Assessed by Post-Intervention Interview

    Intervention acceptability will be assessed through a semi-structured post-intervention interview exploring participants' experiences with the intervention, including perceived usefulness, satisfaction, and recommendations for improvement.

    Week 8

Secondary Outcomes (12)

  • Dyadic Coping Assessed by the Dyadic Coping Inventory (DCI)

    Baseline, Week 8, Week 12

  • Perceived Stress Assessed by the Perceived Stress Scale-10 (PSS-10)

    Baseline, Week 8, Week 12

  • Symptom Burden Assessed by the Edmonton Symptom Assessment System-Revised (ESAS-r)

    Baseline, Week 8, Week 12

  • Cigarette Smoking Status Assessed Using Questions From the Behavioral Risk Factor Surveillance System (BRFSS)

    Baseline, Week 8, Week 12

  • Smokeless Tobacco Use Assessed Using Questions From the Behavioral Risk Factor Surveillance System (BRFSS)

    Baseline, Week 8, and Week 12

  • +7 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants (patient-caregiver dyad together) will take part in 6 Zoom sessions over approximately 6-8 weeks. Each session will last up to 1 hour and will be scheduled at a convenient time. Sessions will be led by trained study staff and include mindfulness (stress reduction) practices, educational content, and dyadic activities. Topics include stress management, physical activity, sleep, nutrition, and communication. The intervention has two components: (1) mindfulness-based stress reduction, and (2) wellness preparation education using the Symptom Management and Survivorship Handbook.

Behavioral: MIND-WELL Intervention (MINDfulness-based Intervention for Navigation of Dyadic WELLness and Education During Transitions)

Comparison Group

NO INTERVENTION

Participants will receive an educational information packet. A study team member will conduct brief check-in phone calls at weeks 2, 4, and 6.

Interventions

The MIND-WELL intervention consists of 6 Zoom sessions over approximately 6-8 weeks with patient-caregiver dyad together. Topics include stress management, physical activity, sleep, nutrition, and communication. Sessions will be led by trained study staff and include mindfulness (stress reduction) practices, educational content, and dyadic activities. The intervention has two components: (1) mindfulness-based stress reduction, and (2) wellness preparation education using the Symptom Management and Survivorship Handbook.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Healthy adults:

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona Cancer Center

Tucson, Arizona, 85719, United States

Location

MeSH Terms

Conditions

Lung NeoplasmsDisease

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Sumin Park, PhD, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2026

First Posted

September 24, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

May 1, 2028

Last Updated

September 24, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations